Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | Pleckstrin G protein, interacting region | 0.0006 | 0.0055 | 0.0077 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0011 | 0.0202 | 0.0286 |
Entamoeba histolytica | Ras guanine nucleotide exchange factor, putative | 0.0004 | 0 | 0.5 |
Entamoeba histolytica | Ras guanine nucleotide exchange factor, putative | 0.0004 | 0 | 0.5 |
Schistosoma mansoni | dihydrofolate reductase | 0.0093 | 0.28 | 0.3964 |
Brugia malayi | Isocitrate dehydrogenase | 0.0011 | 0.0202 | 0.0286 |
Entamoeba histolytica | Ras guanine nucleotide exchange factor, putative | 0.0004 | 0 | 0.5 |
Entamoeba histolytica | Ras guanine nucleotide exchange factor, putative | 0.0004 | 0 | 0.5 |
Entamoeba histolytica | Ras guanine nucleotide exchange factor, putative | 0.0004 | 0 | 0.5 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0322 | 1 | 1 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0109 | 0.329 | 0.4499 |
Entamoeba histolytica | Ras guanine nucleotide exchange factor, putative | 0.0004 | 0 | 0.5 |
Schistosoma mansoni | regulator of G protein signaling | 0.0006 | 0.0055 | 0.0077 |
Onchocerca volvulus | 0.0229 | 0.7064 | 1 | |
Echinococcus multilocularis | segment polarity protein dishevelled | 0.0006 | 0.0055 | 0.0077 |
Echinococcus granulosus | thymidylate synthase | 0.0229 | 0.7064 | 1 |
Brugia malayi | N-terminal motif family protein | 0.0123 | 0.3722 | 0.5269 |
Loa Loa (eye worm) | DIX domain-containing protein | 0.0006 | 0.0055 | 0.0077 |
Brugia malayi | hypothetical protein | 0.0006 | 0.0055 | 0.0077 |
Echinococcus granulosus | regulator of G protein signaling 7 | 0.0006 | 0.0055 | 0.0077 |
Echinococcus granulosus | segment polarity protein dishevelled | 0.0006 | 0.0055 | 0.0077 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0229 | 0.7064 | 1 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0011 | 0.0202 | 0.0286 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0011 | 0.0202 | 0.0286 |
Brugia malayi | Domain found in Dishevelled, Egl-10, and Pleckstrin family protein | 0.0006 | 0.0055 | 0.0077 |
Echinococcus granulosus | regulator of G protein signaling 7 | 0.0006 | 0.0055 | 0.0077 |
Loa Loa (eye worm) | hypothetical protein | 0.0006 | 0.0055 | 0.0077 |
Brugia malayi | DIX domain containing protein | 0.0006 | 0.0055 | 0.0077 |
Entamoeba histolytica | Ras guanine nucleotide exchange factor, putative | 0.0004 | 0 | 0.5 |
Onchocerca volvulus | 0.0006 | 0.0055 | 0.0077 | |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0093 | 0.28 | 0.3964 |
Loa Loa (eye worm) | thymidylate synthase | 0.0229 | 0.7064 | 1 |
Schistosoma mansoni | fyve finger-containing phosphoinositide kinase fyv1 | 0.0006 | 0.0055 | 0.0077 |
Echinococcus multilocularis | segment polarity protein dishevelled | 0.0006 | 0.0055 | 0.0077 |
Loa Loa (eye worm) | hypothetical protein | 0.0006 | 0.0055 | 0.0077 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0322 | 1 | 1 |
Echinococcus multilocularis | regulator of G protein signaling 7 | 0.0006 | 0.0055 | 0.0077 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0011 | 0.0202 | 0.0149 |
Entamoeba histolytica | Ras guanine nucleotide exchange factor, putative | 0.0004 | 0 | 0.5 |
Brugia malayi | Domain found in Dishevelled, Egl-10, and Pleckstrin family protein | 0.0006 | 0.0055 | 0.0077 |
Entamoeba histolytica | Ras guanine nucleotide exchange factor, putative | 0.0004 | 0 | 0.5 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0093 | 0.28 | 0.5 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0229 | 0.7064 | 1 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0011 | 0.0202 | 0.0286 |
Onchocerca volvulus | Segment polarity protein dishevelled homolog | 0.0006 | 0.0055 | 0.0077 |
Entamoeba histolytica | Ras guanine nucleotide exchange factor, putative | 0.0004 | 0 | 0.5 |
Schistosoma mansoni | z-protein (S1r protein) | 0.0006 | 0.0055 | 0.0077 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0011 | 0.0202 | 0.0202 |
Brugia malayi | hypothetical protein | 0.0006 | 0.0055 | 0.0077 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0322 | 1 | 1 |
Brugia malayi | thymidylate synthase | 0.0229 | 0.7064 | 1 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0322 | 1 | 1 |
Loa Loa (eye worm) | G protein signaling regulator EGL-10 | 0.0006 | 0.0055 | 0.0077 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0011 | 0.0202 | 0.0286 |
Schistosoma mansoni | dep domain containing protein | 0.0006 | 0.0055 | 0.0077 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.0109 | 0.329 | 0.329 |
Brugia malayi | isocitrate dehydrogenase | 0.0011 | 0.0202 | 0.0286 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0011 | 0.0202 | 0.0286 |
Onchocerca volvulus | Rap guanine nucleotide exchange factor 1 homolog | 0.0123 | 0.3722 | 0.5269 |
Echinococcus multilocularis | thymidylate synthase | 0.0229 | 0.7064 | 1 |
Entamoeba histolytica | Ras guanine nucleotide exchange factor, putative | 0.0004 | 0 | 0.5 |
Schistosoma mansoni | dishevelled | 0.0006 | 0.0055 | 0.0077 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0011 | 0.0202 | 0.0149 |
Mycobacterium ulcerans | thymidylate synthase | 0.0229 | 0.7064 | 1 |
Echinococcus granulosus | dihydrofolate reductase | 0.0093 | 0.28 | 0.3964 |
Brugia malayi | dihydrofolate reductase family protein | 0.0093 | 0.28 | 0.3964 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0011 | 0.0202 | 0.0202 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.3722 | 0.5269 |
Echinococcus granulosus | segment polarity protein dishevelled | 0.0006 | 0.0055 | 0.0077 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0109 | 0.329 | 1 |
Entamoeba histolytica | Ras guanine nucleotide exchange factor, putative | 0.0004 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0006 | 0.0055 | 0.0077 |
Entamoeba histolytica | Ras guanine nucleotide exchange factor, putative | 0.0004 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.0109 | 0.329 | 0.4657 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.0093 | 0.28 | 0.3786 |
Brugia malayi | regulator of G-protein signaling egl-10 | 0.0006 | 0.0055 | 0.0077 |
Brugia malayi | Dihydrofolate reductase | 0.0093 | 0.28 | 0.3964 |
Schistosoma mansoni | dishevelled | 0.0006 | 0.0055 | 0.0077 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0322 | 1 | 1 |
Echinococcus granulosus | Pleckstrin G protein interacting region | 0.0006 | 0.0055 | 0.0077 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0011 | 0.0202 | 0.0286 |
Entamoeba histolytica | hypothetical protein | 0.0004 | 0 | 0.5 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0011 | 0.0202 | 0.0286 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.0229 | 0.7064 | 1 |
Echinococcus multilocularis | regulator of G protein signaling 7 | 0.0006 | 0.0055 | 0.0077 |
Echinococcus multilocularis | dihydrofolate reductase | 0.0093 | 0.28 | 0.3964 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 0 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 3.86 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 6.59 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 7.2 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 29 % | GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 38 % | GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM. | ChEMBL. | 20485427 |
Inhibition (functional) | = 100 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition frequency index (IFI) (functional) | = 2.82 | Inhibition Frequency Index (IFI) | GSK. | 20485427 |
Percent growth inhibition (functional) | = -1 % | Percent inhibition of P. falciparum lactate dehydrogenase activity (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 29 % | Percent inhibition of P. falciparum Dd2 growth (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 38 % | Percent inhibition of HepG2 growth (at 10 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 101 % | Percent inhibition of P. falciparum 3D7 growth (at 2 uM) | GSK. | 20485427 |
XC50 (functional) | = 6.08 | XC50 determination of P. falciparum 3D7 growth | GSK. | 20485427 |
XC50 (functional) | = 0.83 uM | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth. | ChEMBL. | 20485427 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.